MeSH D000787 - angina pectoris
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Nitroglycerin | Rectiv |  | 2011-06-21 |  |  |
| Able Laboratories | Atenolol | Atenolol |  | 2004-07-30 |  |  |
| Accord Healthcare | Ivabradine | Ivabradine Accord |  | 2017-05-22 |  |  |
| Metoprolol | Metoprolol |  | 2022-10-18 |  |  | |
| Ranolazine | Ranolazine |  | 2021-05-18 |  |  | |
| Ajanta Pharma | Ranolazine | Ranolazine |  | 2019-05-28 |  |  |
| Alembic Pharmaceuticals | Metoprolol | Metoprolol |  | 2013-05-28 |  |  |
| Hydrochlorothiazide, Metoprolol | Metoprolol Hydrochlorothiazide |  | 2013-11-06 |  |  | |
| Alkem Laboratories | Metoprolol | Metoprolol |  | 2020-11-25 |  |  |
| Ranolazine | Ranolazine |  | 2020-11-30 |  |  |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/3
Phase 2
50%3/6
Phase 3
85%28/33
Approved: 22Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use